Bottom line
How much do GDOC and ETHSX overlap?
51% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 56.0% of GDOC's assets and 47.6% of ETHSX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings GDOC and ETHSX have in common
| Holding | % of GDOC | % of ETHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 13.28% | 12.47% | 12.47% |
| Johnson & Johnson JNJ | 8.07% | 6.45% | 6.45% |
| Merck & Company Inc MRK | 5.94% | 5.08% | 5.08% |
| Astrazeneca Plc AZN | 4.84% | 6.24% | 4.84% |
| Thermo Fisher Scientific Inc TMO | 4.52% | 2.79% | 2.79% |
| Argenx Se ARGX | 4.07% | 1.61% | 1.61% |
| Intuitive Surgical Inc ISRG | 3.90% | 2.72% | 2.72% |
| Boston Scientific Corp BSX | 3.78% | 2.18% | 2.18% |
| Lonza Group Ag LONN | 2.80% | 1.77% | 1.77% |
| Royalty Pharma Plc RPRX | 1.77% | 1.58% | 1.58% |
| Mettler-toledo International Inc MTD | 1.59% | 1.36% | 1.36% |
| Vertex Pharmaceuticals Inc VRTX | 1.48% | 3.38% | 1.48% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GDOC
- Guardant Health Inc — 5.34%
- Hoya Corp — 3.53%
- Edwards Lifesciences Corp — 2.98%
- Dexcom Inc — 2.79%
- Agilent Technologies Inc — 2.77%
- Roivant Sciences Ltd — 2.39%
- Cencora Inc — 2.34%
- Apogee Therapeutics Inc — 1.97%
- Penumbra Inc — 1.61%
- Goldman Sachs Trust — 1.43%
- Cytokinetics Inc — 1.40%
- Ionis Pharmaceuticals Inc — 1.37%
- Xenon Pharmaceuticals Inc — 1.35%
Only in ETHSX
- AbbVie Inc — 6.46%
- UnitedHealth Group Inc — 5.49%
- Roche Holding AG — 5.44%
- Bristol-Myers Squibb Co — 4.25%
- Gilead Sciences Inc — 3.34%
- Sanofi SA — 2.95%
- Stryker Corp — 2.21%
- Medtronic PLC — 1.80%
- Novo Nordisk A/S — 1.71%
- Abbott Laboratories — 1.65%
- Novartis AG — 1.65%
- Neurocrine Biosciences Inc — 1.41%
- Straumann Holding AG — 1.34%
Asset mix
| Asset type | GDOC | ETHSX |
|---|---|---|
| Stocks | 98.5% | 99.4% |
| Cash & short-term funds | 1.4% | 0.3% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | GDOC | ETHSX |
|---|---|---|
| US | 76.3% | 69.4% |
| CH | 3.9% | 10.2% |
| GB | 6.6% | 7.8% |
| NL | 4.1% | 2.0% |
| JP | 3.5% | — |
| FR | 0.6% | 3.2% |
| DK | — | 2.9% |
| BM | 2.4% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do GDOC and ETHSX overlap?
What stocks do GDOC and ETHSX have in common?
Should I own both GDOC and ETHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.